Health & Medicine Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health & Medicine Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Allergic Rhinitis
Rhinitis immunotherapy using specific subcutaneous allergen is better than drugs
September 1st, 2003
Allergic rhinitis may be treated and reduced by subcutaneous allergen specific immunotherapy, instead of drugs. According to recent research from Denmark, "Allergen-specific immunotherapy in the treatment of allergic rhinitis has a well-documented clinical efficacy that indicates a statistically significant and clinically relevant reduction in symptom scores and the need for pharmacotherapy. "The clinical efficacy of recently published studies is equivalent to or superior to the effect of standard anti-allergic drugs. Additional advantages are related to a downregulation of the allergic phenotype with the additional induction of a Thl cytokine...
Source: Health & Medicine Week (2003-09-01)
|
